Company news
Koru Medical Systems, Inc. (NASDAQ:KRMD) news
Every Koru Medical Systems, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance :: KORU Medical Systems (KRMD)
August 5, 2026
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st ...
May 18, 2026
KORU Medical Systems Announces First Quarter 2026 Results
May 6, 2026
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
April 16, 2026
KORU Medical Systems Announces EU MDR Certification for the Freedom60 Infusion Pump with Prefilled Syringe Compatibility
March 16, 2026
KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility
March 13, 2026
KORU Medical Systems Announces CEO Transition
March 12, 2026
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 20...
March 12, 2026
KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
February 26, 2026
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO, Expanding Label for FreedomEDGE Infusion System
January 30, 2026
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Inf...
January 29, 2026
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
January 12, 2026
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 5, 2026
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
December 30, 2025
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
December 16, 2025
KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/...
November 17, 2025
KORU Medical Systems to Participate in Upcoming Investor Conferences
November 13, 2025
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
November 12, 2025
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
November 4, 2025
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
October 22, 2025
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
September 18, 2025
Cirtec Medical Announces Appointment of New Chief Executive Officer
August 28, 2025
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
August 6, 2025
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 30, 2025
KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025
July 16, 2025
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
July 7, 2025
KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes
June 11, 2025
KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance
May 7, 2025
KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025
April 16, 2025
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Yea...
March 12, 2025
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
February 19, 2025
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
February 6, 2025
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
January 30, 2025
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Pos...
January 13, 2025
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference
November 25, 2024
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 G...
November 13, 2024
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for U...
October 31, 2024
KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024
October 23, 2024
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
September 5, 2024
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
August 7, 2024
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
July 24, 2024
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
July 17, 2024
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
July 2, 2024
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcu...
June 5, 2024
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
June 4, 2024
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
May 14, 2024
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
May 1, 2024
KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024
April 17, 2024